Evidence map›Paper›PMID 19647312›Full record

ArticleBiomaterials2009

Multimeric peptide-based PEG nanocarriers with programmable elimination properties.

Simi Gunaseelan, Shahriar Pooyan, Peiming Chen, Mahta Samizadeh, Matthew S Palombo, Stanley Stein, Xiaoping Zhang, Patrick J Sinko

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Optimal structural design of mannosylated nanocarriers for macrophage targeting.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Simi GunaseelanDepartment of Pharmaceutics, Rutgers University, NJ 08854, USA.
Shahriar Pooyan
Peiming Chen
Mahta Samizadeh
Matthew S Palombo
Stanley Stein
Xiaoping Zhang
Patrick J Sinko
Rutgers, The State University of New Jersey · US

Funding

Enhancing Intestinal & Brain Uptake of Anti-AIDS DrugsR37AI051214 · NIAID · RUTGERS, THE STATE UNIV OF N.J. · PI SINKO, PATRICK J. · 2006 to 2015
$4.4M
Enhancing Intestinal &Brain Uptake of Anti-AIDS Drugs.R01AI051214 · NIAID · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI SINKO, PATRICK J. · 2002 to 2005
$1.1M
NIAID NIH HHS AI51214NIAID NIH HHS R01 AI051214NIAID NIH HHS R37 AI051214
6 · The paper itself

Abstract

In the current study, the design, synthetic feasibility and biochemical characterization of biodegradable peptidic PEG-based nanocarriers are described. The components were selected to influence the body elimination pathway upon nanocarrier biodegradation. Two prototypical nanocarriers were prepared using non-PEGylated and PEGylated peptidic cores [CH(3)CO-(Lys-betaAla-betaAla)(X)-Cys-CONH(2) (X=2, 4)]. A homodimeric nanocarrier with 4 copies of fluorescein-PEG5kDa was synthesized by linking two PEGylated peptidic cores (X=2) using a disulfide bond. A dual labeled heterodimeric nanocarrier with 2 copies of fluorescein-PEG5kDa and 4 copies of Texas Red was also synthesized. Optimum conditions for linking imaging agents, PEG, or a peptidic core to a peptidic core were determined. Significantly higher yields (69% versus 30%) of the PEGylated peptidic core were obtained by using 2 copies of beta-alanine as a spacer along with increasing DMSO concentrations, which resulted in reduced steric hindrance. Stoichiometric addition of the components was also demonstrated and found to be important for reducing polydispersity. Nanocarrier biodegradation was evaluated in simulated intracellular and extracellular/blood environments using 3 mm and 10 microm glutathione in buffer, respectively. The nanocarrier was 9-fold more stable in the extracellular environment. The results suggest selective intracellular degradation of the nanocarrier into components with known body elimination pathways.

Indexed as

Absorbable ImplantsBody FluidsCoated Materials, BiocompatibleDimerizationDrug CarriersMaterials TestingPeptidesPolyethylene GlycolsCoated Materials, BiocompatibleDrug CarriersPeptidesPolyethylene Glycols

Identifiers

PMID19647312
PMCPMC2728785
OpenAlexW1995545661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.